INS and metabolic dysfunction-associated steatotic liver disease: Because inflammation and insulin resistance are considered critical for NAFLD progression [20], signaling pathways, including insulin signaling cascades, the NF-κB signaling pathway, and the MAPK signaling pathway, have key roles in NAFLD [21, 22].